Skip to content
Screener

Erasca, Inc. ERAS Total Operating Expenses

Total Operating Expenses at other companies

Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
$505.13M+90.8%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$48.77M+1.8%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$115.1M+36.4%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$46.11M-30.9%
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
$57.99M+66.3%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$30.93M-27.9%

Other financials

Income statement

See full
Operating income-$187.9M-427%
Net income-$183.4M-492%
EPS (diluted)-$0.60-445%

Balance sheet

See full
Cash & equivalents$47.3M-33.0%
Total debt$46.0M-9.6%
Total equity$393.5M-1.5%
Total assets$461.2M-2.1%

Cash flow

See full
Operating cash flow-$27.4M+13.2%
CapEx$36.0K-56.6%
Free cash flow-$27.4M+13.3%

Valuation

See full
Market cap$6.34B+1,466%
Enterprise value$6.34B+1,533%

Returns & leverage

See full
Return on equity-69.9%+77.1pp
Debt / equity0.1×0.0×
Current ratio9.5×-2.8×

Where this comes from

Reported directly by Erasca, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The source filing: Erasca, Inc.’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 4:13 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-216788
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Research and development$27,265$25,969
In-process research and development150,000
General and administrative10,6469,661
Total operating expenses187,91135,630
Loss from operations(187,911)(35,630)
Other income (expense)
Interest income4,4494,740
Other income (expense), net22(76)

Item 1. Financial Statements.

FAQ

What is Erasca, Inc.'s total operating expenses?
Erasca, Inc. (ERAS) reported total operating expenses of $187.91M in Q1 2026.
How has Erasca, Inc.'s total operating expenses changed year-over-year?
Erasca, Inc.'s total operating expenses increased by 427.4% year-over-year, from $35.63M to $187.91M.
What is the long-term trend for Erasca, Inc.'s total operating expenses?
Over 4 years (2021 to 2025), Erasca, Inc.'s total operating expenses has grown at a 3.1% compound annual growth rate (CAGR), from $124.88M to $140.91M.
What does total operating expenses mean?
The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.

Ask your AI about Erasca, Inc.'s total operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude